Health24.com | Coronavirus morning update: Lockdown curfew, understanding level 4, and high-speed science

WHAT’S HAPPENING IN SA

Cases update: 

The latest number of confirmed cases is 4 361.

According to the latest update, 86 deaths have been recorded in the country.

So far, 161 004 tests have been conducted, with more than 8 600 new tests.

READ MORE |All the confirmed cases of coronavirus in SA

Latest news:

As of 1 May, a national curfew from 20:00 to 05:00 will be in place and it will be applicable to everyone except essential workers traveling to and from work.

The country is expected to move from a Level 5 to a Level 4 lockdown, allowing limited economic activity but keeping most existing measures in place.

On Saturday, Minister of Cooperative Governance and Traditional Affairs Nkosazana Dlamini-Zuma and Minister of Trade and Industry Ebrahim Patel addressed the media on the Level 4 lockdown.

While restaurants will be closed for sit-down meals when the country moves to Level 4 next Friday, the movement of takeaway food will be allowed.

READ MORE | Lockdown curfew from 20:00 to 05:00 starting on 1 May

It is now up to South Africans to ensure that the country doesn’t move back to a Level 5 lockdown, Minister of Cooperative Governance and Traditional Affairs Nkosazana Dlamini-Zuma said on Saturday.

On Thursday, President Cyril Ramaphosa announced that the government would use a five-level phased approach towards easing lockdown restrictions. The country is currently on Level 5 – the most restrictive level – but this will be eased to Level 4 on 1 May.

On Saturday, Dlamini-Zuma unpacked what this meant.

“Level 4 means the lockdown is still in place,” she said.

READ MORE | Up to South Africans to ensure we don’t go back to Level 5

The rate of Covid-19 infections is lower than the global one, according to the acting director-general of the Department of Health, Dr Anban Pillay.

At a press briefing on Saturday with Cooperative Governance and Traditional Affairs Minister Nkosazana Dlamini-Zuma and Trade and Industry Minister Ebrahim Patel, Pillay said currently, the trend suggested about 3% of people, who were tested, were positive.

This has been the trend since testing started.

“That is way lower than the global experience, which has been much higher at around 10%.”

READ MORE | SA’s Covid-19 infection rate ‘lower than the global average’

From 1 May, South Africans will be allowed to buy clothes and cigarettes, and order fast food.

A number of businesses can also re-open, it was announced at a media briefing on Saturday.

South Africa will embark on a staged reopening of the economy, starting with a level 4 on the first of May, to help slow down the spread of coronavirus, and ensure that health authorities are not overwhelmed, cooperative governance and traditional affairs minister Nkosazana Dlamini-Zuma said. 

READ MORE | Lockdown level 4: What will be allowed

The unconditional sale of liquor will only be permitted when South Africa reaches Level 2 of its “risk adjusted strategy” to fight Covid-19. 

Details of the country’s five-level economic reopening were released on Saturday, including when which industries will be allowed to return to work. South Africa will be moving from Level 5 to 4 on May 1st.

Cooperative governance and traditional affairs minister Nkosazana Dlamini-Zuma warned that if there was a sudden surge in infections, South Africa – or the most-affected parts of the country – could move back to a stricter level.

READ MORE | You’ll only be able to buy booze at Level 3 – and only on some weekday mornings

WHAT’S HAPPENING IN THE REST OF THE WORLD 

Cases update:

For the latest global data, follow this interactive map from Johns Hopkins University & Medicine.

Late on Saturday night, positive cases worldwide were more than 2.88 million, while deaths were more than 200 000.

The United States had the most cases in the world – nearly 930 000, as well as the most deaths – more than 53 000.

READ MORE | All the confirmed cases worldwide

Latest news:

Leading manufacturers of cleaning products have issued statements warning their customers not to attempt to inject themselves with disinfectants after US President Donald Trump incorrectly claimed that doing so might cure COVID-19.

Trump suggested at a White House coronavirus briefing on Thursday that because disinfectant can kill the virus on external surfaces, perhaps it could be used internally to treat coronavirus patients.

“I see the disinfectant where it knocks it out in a minute,” he said. “One minute. And is there a way we can do something like that, by injection inside or almost a cleaning?” he said. “So it’d be interesting to check that.”

He added: “I’m not a doctor. But I’m, like, a person that has a good you-know-what.”

The president also suggested that ultraviolet light, used internally, might help treat Covid-19.

Following his comments, RB, which manufacturers disinfectants for the European market, issued a statement urging the public never to attempt to consume its products.

READ MORE | Bleach manufacturers have warned people not to inject themselves with disinfectant after Trump falsely suggested it might cure the coronavirus

LATEST RESEARCH

Epidemiological terms are fast becoming part of everyday language. Terms like “flattening the curve”, “antibody tests” and “infection control” pepper conversations in supermarket queues and Zoom meetings.

Scientists must publicly share and explain, more now than ever before, the science behind efforts to stop the Covid-19 virus in its tracks. And, apart from some fake news and bad armchair epidemiology, it generally seems to work. In my experience at least, most people seem to talk about the virus with a decent scientific understanding of the basic mechanisms of transmission and the need to follow protective measures.

The communication of science to the public can however have negative consequences if the science underpinning the conversation is not as robust as it ideally should be. This risk is heightened in an emergency environment where not all the scientific method’s usual checks and balances are in place.

The rate at which scientific knowledge about Sars-CoV-2 (the virus that causes Covid-19) has been acquired is a remarkable collective achievement. Just five months ago no-one knew about the virus’s existence, but today it is the subject of study on an unprecedented scale.

In the face of a public health emergency, academic secrecy appears to have been suspended and scientific collaboration has increased. Leading medical journals have made their Covid-19 articles free-to-read for all. More than 200 clinical trials have been launched, in many cases uniting hospitals and laboratories from different countries. The hunt is on for a vaccine, a number of antiviral drug trials are on the go and new diagnostic tests are rapidly being developed and validated.

READ MORE | Covid-19: The pros and cons of high-speed science

HEALTH TIPS (as recommended by the NICD and WHO)

• Maintain physical distancing – stay at least one metre away from somebody who is coughing or sneezing

• Practise frequent hand-washing, especially after direct contact with ill people or their environment

• Avoid touching your eyes, nose and mouth, as your hands touch many surfaces and could potentially transfer the virus

• Practise respiratory hygiene – cover your mouth with your bent elbow or tissue when you cough or sneeze. Remember to dispose the tissue immediately after use.

READ MORE: Coronavirus 101 

Image credit: Getty Images

Share Button

Health24.com | Coffee keeping you going during lockdown? Choose filtered as the healthiest option

We all have our snack or beverage of choice to keep us sustained and energised when we’re working from home. If you need coffee to deliver your best, the least you can do is to make sure it’s as healthy as possible. 

Research to examine the links between the way you brew your coffee and the risks of heart attacks and death concluded that filtered coffee is your healthiest choice.

This study was published in The European Journal of Preventive Cardiology.

“Our study provides strong and convincing evidence of a link between coffee brewing methods, heart attacks and longevity,” said study author Professor Dag S. Thelle of the University of Gothenburg, Sweden.

“Unfiltered coffee contains substances which increase blood cholesterol. Using a filter removes these and makes heart attacks and premature death less likely,” he stated. 

Coffee and cholesterol?

Like it or loathe it, coffee is a popular beverage worldwide and there have been many debates about its benefits. According to a news report, Professor Thelle discovered nearly three decades ago that drinking coffee was linked with higher cholesterol – specifically the “bad” LDL cholesterol.

But experiments concluded that this side-effect was largely caused by substances that can be removed using a filter. A cup of unfiltered coffee contains almost 30 times the concentration of the substance that is known to raise LDL cholesterol.

Thelle said: “We wondered whether this effect on cholesterol would result in more heart attacks and death from heart disease. But it was unethical to do a trial randomising people to drink coffee or not. So, we set up a large population study, and several decades later we are reporting the results.”

What the study entailed

This study was conducted between 1985 and 2003 and looked at 508 747 healthy men and women between the ages of 20 and 79. They all completed a questionnaire on the type of coffee they consumed, and data on general health factors such as height, weight, blood pressure and cholesterol were collected.

A total of 46 341 participants died over the course of 20 years. Of those, 12 621 deaths were due to cardiovascular disease. Of the cardiovascular deaths, 6 202 were caused by a heart attack.

Compared to no coffee, filtered brew was linked with a 15% reduced risk of death from any cause during follow up, according to the news report. In death from cardiovascular disease, filtered brew was associated with a 12% decreased risk of death in men and a 20% lowered risk of death in women compared to no coffee.

The lowest mortality was among those who drank one to four cups of filtered coffee per day.

Professor Thelle said: “The finding that those drinking the filtered beverage did a little better than those not drinking coffee at all could not be explained by any other variable such as age, gender, or lifestyle habits. So, we think this observation is true.”

Choose the best you can afford

Filtered brew was also less risky than the unfiltered beverage for death from any cause, death due to cardiovascular disease, and deaths from heart attacks. “Our analysis shows that this was partly because of the cholesterol-increasing effect of unfiltered coffee,” said Professor Thelle.

Professor Thelle noted that unfiltered coffee did not necessarily raise the risk of death compared to completely cutting out coffee.

He said: “We believe that some women and younger men drinking unfiltered coffee switched to filtered, thereby reducing the strength of the association with cardiovascular mortality, whereas older men were less inclined to change their habits.”

The outcome? Keep your cholesterol low and your heart healthy by choosing the best filtered coffee you can afford.

Image credit:

Share Button

Coronavirus: UK hospital deaths pass 20,000

It comes as Prime Minister Boris Johnson is to return to work in Downing Street on Monday morning.

Share Button

Health24.com | Covid-19: The pros and cons of high-speed science

Epidemiological terms are fast becoming part of everyday language. Terms like “flattening the curve”, “antibody tests” and “infection control” pepper conversations in supermarket queues and Zoom meetings.

Scientists must publicly share and explain, more now than ever before, the science behind efforts to stop the Covid-19 virus in its tracks. And, apart from some fake news and bad armchair epidemiology, it generally seems to work. In my experience at least, most people seem to talk about the virus with a decent scientific understanding of the basic mechanisms of transmission and the need to follow protective measures.

The communication of science to the public can however have negative consequences if the science underpinning the conversation is not as robust as it ideally should be. This risk is heightened in an emergency environment where not all the scientific method’s usual checks and balances are in place.

Unprecedented speed

The rate at which scientific knowledge about Sars-CoV-2 (the virus that causes Covid-19) has been acquired is a remarkable collective achievement. Just five months ago no-one knew about the virus’s existence, but today it is the subject of study on an unprecedented scale.

In the face of a public health emergency, academic secrecy appears to have been suspended and scientific collaboration has increased. Leading medical journals have made their Covid-19 articles free-to-read for all. More than 200 clinical trials have been launched, in many cases uniting hospitals and laboratories from different countries. The hunt is on for a vaccine, a number of antiviral drug trials are on the go and new diagnostic tests are rapidly being developed and validated.

At the height of the HIV/AIDS epidemic in the 1990s, researchers and clinicians, spurred on by activists, rallied to combat the disease in what was then an unprecedented effort. But today’s technology and the pace of information-sharing surpasses what was possible 30 years ago.

Professor Tulio de Oliveira, a geneticist at KRISP in KwaZulu-Natal, said in a recent Data@breakfast webinar that “in just 100 days the scientific community has identified the virus, sequenced the genome, understood transmission, understood the proteins, and had an understanding of the receptor that enters the cell”. He said this came about because scientists decided to release their data quickly. “We talk about from sample to scientific results in days,” he said.

“This has completely changed the way we do traditional science.” de Oliveira said in a pre-Covid-19 world it could take up to 100 days from submission of a science paper to it being accepted for publication in a journal. “[Now]in that time we already have thousands of publications.”

Warning bells

Warning bells are ringing however about the poor quality of some scientific research in these pressurised times. The politicisation of science and hype in the media around clinically unproven drug treatments can create public confusion and fuel unrealistic expectations.

The closely related antimalarial drugs chloroquine and hydroxychloroquine recently became household names after US President Donald Trump touted them as proven treatments for Covid-19. This was after early trials suggested they may have some efficacy in the treatment of people with the disease. The public responded by buying up the drugs – in the process putting those who need them for rheumatoid arthritis and other auto immune conditions at risk.

Some scientists have warned against over-interpreting the early studies due to methodological flaws.  Some hydroxychloroquine studies have since been abandoned, and some have suggested the drugs may increase the risk of cardiac arrest in patients with Covid-19 disease. While most scientists seem to consider hydroxychloroquine worth studying further, most also seem to agree that the jury is very much still out.

“The problem is when trial results come out and are presented to the media without important contextualisation, peer review and critique,” says Graeme Meintjes, an infectious diseases physician at the University of Cape Town. “A treatment (drug) needs to be safe and effective and focussed on patient outcomes. We are interested in saving lives, faster recovery and reduced hospitalisation.”

Too many small trials?

The urgency to do research and then to publish one’s findings as quickly as possible is entirely understandable given the severe toll Covid-19 is taking. But might the publication of findings from small, methodologically flawed studies end up doing more harm than good?

There is currently a deluge of small trials being registered which could result in low quality evidence, according to Helen Macdonald, research editor of the British Medical Journal(BMJ). In a recent “BMJ Evidence-based Medicine” podcast she said many of the trials could not be compared and was wasteful research.

“There is a need for less speed and more careful thought and for proper blinded randomised control trials done properly,” she said.

Andy Gray, a pharmacologist at the University of KwaZulu-Natal, has similar concerns. He says the new trend of fast-paced research could be risky in the future. “Speed will be valued over quality, with a weakening of the peer review process. That risks poor-quality research entering the ‘literature’ to a far greater extent than is already the case.”

Gray says “underpowered clinical trials” (meaning small trials with few participants) with inadequate processes for blinding and randomisation risk results that can be misleading or misinterpreted.

“When inclusion and exclusion criteria for participating in the trials are poorly determined, or applied, and clinician choice to alter allocations or regimens is allowed, the risks of biases are also increased.” This ultimately undermines the research study, he says. Gray adds: “When attempts are then made to synthesise the literature, we are left with only poor quality evidence on which to make decisions.”

Meintjes says there are an unprecedented number of similar hydroxychloroquine studies, addressing similar scientific hypothesis. “We now need larger studies,” he says, that will look at patient related outcomes.

As with HIV networks studies, Gray says, co-ordination and multi-centre studies for Covid-19 are possible, but these trials take time and have to be meticulously conducted and monitored.

Two large Covid-19 studies have been launched that should help avoid some of the pitfalls of doing many smaller trials with varying methodologies. These are both randomised controlled trials that will recruit large numbers of people to a standardised protocol that allows for a meaningful comparison of different Covid-19 treatments.

The United Kingdom’s RECOVERY trial has recruited more than 5 000 patients in over 165 hospitals and the SOLIDARITY trial, coordinated by the World Health Organisation, has four treatment arms and involves over 100 countries. Spotlight previously reported on South Africa’s participation in the SOLIDARITY trial and published an opinion piece on why such large, multi-arm clinical trials are needed for Covid-19. 

Single-arm trials 

One benefit of multi-arm trials such as RECOVERY and SOLIDARITY is that they allow us to compare treatments with each other and with placebo. Single-arm trials (where a treatment is not directly compared to any other treatment), on the other hand, do not allow for direct comparisons and accordingly provide less certain findings. They are however generally easier and quicker to do.

In a recent Covid-19 drug study reported in the New England Journal of Medicine (NEJM) for example, data were presented for “61 patients who received at least one dose of the antiviral drug remdesivir”, but in seven patients there were no post-treatment data and one patient had a dosing error. There was also no control arm (in which one group of participants is not given the drug so they can be compared with the group receiving the drug).

Gray says although a University of Chicago Medicine study recruited more patients (125, of which 113 were described as “severe”) in another trial of remdesivir, there was no control arm either, so no means of comparison.

The trial results, yet to be peer-reviewed and published, were leaked to the media after they were discussed at a university faculty meeting and soon after started making waves on Twitter.

The authors of an article published in the NEJM and which appeared after the remdesivir study, highlighted concerns about how evaluating and approving drugs can go awry during a public health crisis. They said: “It is a false dichotomy to suggest that we must choose between rapid deployment of treatments and adequate scientific scrutiny. For the Covid-19 pandemic and other pressing medical challenges, the health of individual patients and the public at large will be best served by remaining true to our time-tested approach to clinical trial evidence and drug evaluation, rather than cutting corners and resorting to appealing yet risky quick fixes.”

BCG: Correlation is not cause

Another study grabbing media attention in South Africa suggested a correlation between the century-old Bacillus Calmette–Guérin (BCG) vaccine and protection against Covid-19. The BCG vaccine is used in South Africa and various other countries with high TB burdens to prevent severe forms of TB in young children. 

Following the publication of the study, Facebook and other social media platforms quickly ignited with BCG being declared a “game changer”. 

But it is worth considering where the study was published. It was uploaded to the preprint server medRxiv, an online archive that shares academic research before it has been peer-reviewed and published in journals. In normal times, publication of such a study without peer-review would be frowned upon by many.

A number of critiques of the study have since been published (here is a particularly good one). One point some have made is that correlation is not cause and that there are other more plausible explanations for the correlation between BCG and Covid-19. It is also possible that the correlation will vanish as Covid-19 numbers increase in poorer countries with widespread BCG vaccination.

Given the compelling criticisms that have been published of the article, it seems unlikely that the article in its original form would have made it through peer-review at a reputable journal without very significant alterations. As such, the affair both raises questions over the need for scientific peer-review and over the media’s handling of studies that have not been peer-reviewed. 

*Adele Baleta is an independent science writer, media consultant and trainer.
This article was produced by SPOTLIGHT – health journalism in the public interest. SIGN UP for our newsletter. 

READ | Many approved drugs may hold promise against coronavirus

READ | Countries worldwide should help Africa fight coronavirus, say researchers

READ | Paper towels more effective at removing virus than air dryers

Image credit: National Cancer Institute, Unsplash

Share Button

Coronavirus test online slots booked up within hour of site reopening

Millions of key workers and people they live with can apply for a coronavirus test online.

Share Button

Being Too Quiet

When I was younger, I was conditioned to yield to authority. Go to school. Go to church. Obey the parents.

One of the most common commands was: Be quiet. Hush. Pipe down. Silence is a virtue. Children should be seen and not heard.

So I learned to stay quiet – about problems, about desires, about feelings. I developed a rich inner world, but supposedly it wasn’t meant to be shared. My thoughts were to be kept mostly to myself.

On the positive side, that made me more self-reliant. But it also ensured that I didn’t get to experience what I wanted, as the wants and the communication both got suppressed under a blanket of silence.

It took a long time to learn that it was okay to communicate about needs, desires, and feelings. As I got older, I found people encouraging me to open up and share more, such as friends in college. That was difficult to do though. I wasn’t used to it. When people wanted to know more about me, it felt like they were shining a burning spotlight into my soul. I couldn’t go there, so I shared various masks instead. I kept people at a safe distance.

But this left me stuck inside my own thought bubble with no way to break free from it. Because I couldn’t talk about what I felt, needed, and wanted, no one could help me make improvements. Even if people offered support, it was misguided because they didn’t really know what I wanted. They had to guess, and their guesses were wrong.

As I began making a long-term investment in personal development, I read lots of books and listened to many audio programs. I liked it when other people share their stories, goals, ambitions, mistakes, and feelings. Every now and then, I’d come across something that struck me as really honest and authentic. And I silently thought to myself, I could never do that.

What probably helped me shift the most was meeting people who were unconditionally accepting of other people’s wants, needs, and feelings. Around such people I felt like I could open up a little more. I sensed that I could trust them, even though I wasn’t sure why. I just naturally found myself sharing more honestly with them. It would feel off if I wore my masks around them too often. I was surprised when they didn’t judge me for my candor. They actually seemed to like and appreciate hearing the real truth and going deeper than the surface masks. It took a while for me to warm up to that since it was outside of my comfort zone.

There was a long progression with many steps forward and backward, like an awkward dance, but eventually I felt more comfortable sharing more of my inner world with people. I could talk about desires, problems, and feelings openly. I didn’t always feel drawn to do that, but I didn’t feel particularly blocked in doing so either.

And that’s mainly because I got to see the positive shifts in others when I did so. I made more authentic friends this way. But I was also able to experience more of what I wanted.

By saying, “I want to kiss you” instead of keeping silent, I kissed more.

By saying, “I have this frustrating tech problem,” I solved more tech problems.

By saying, “I feel so blah today,” I understood and shifted my feelings more easily, and my default state gradually became happier.

Initially my timing was off though. I was too hesitant to open up when the timing was right because the intensity was too great. But by waiting for the intensity to come down, I was late in expressing myself. I realized how lame I was being when I kept missing opportunities because of that tendency to hesitate.

For a while I got results like these:

Me: I kinda wanted to kiss you last night.

Her: I wish you’d said something. I would have gladly kissed you back.

Me: D’oh!

Me: Last month I had this frustrating tech problem that was a real mess, but I finally got it figured out.

Her: Oh… why didn’t you tell me about that when we last spoke? I had the same problem before, and I could have shown you how to fix it in two seconds.

Me: D’oh!

Me: I was feeling so blah yesterday.

Her: I could tell. I was thinking of offering you a nice head scratching, but it looked like you wanted some space.

Me: D’oh!

Why do we do this to ourselves?

Sharing late is at least better than not sharing. When you see how many opportunities you’re missing due to silence, it’s good motivation to be more courageous and speak up sooner.

Silence can be a virtue, but keeping quiet can be really problematic if you overdo it. How can you tell the difference?

Is the silence peaceful? Does it feel good to remain silent? If so, then enjoy the silience.

Is the silence stress-inducing? Are your thoughts and feelings churning over unresolved issues? If so, then speak up. Get that energy flowing outwardly. Don’t just keep it bottled up inside.

Also be careful not to merely vent sideways. Venting sideways would be doing the equivalent of this:

Me: I wanted to kiss her last night, but I couldn’t bring myself to go there.

Him: I saw the two of you together, and I’m pretty sure she would have liked it if you did.

Me: D’oh!

This is telling the wrong person. When you do this sort of thing, you’re channeling the energy sideways, which isn’t in the direction of resolution. It’s a sneakier form of staying silent. You may think you’re speaking up, but are you?

Sharing needs, desires, and feelings isn’t easy, especially if you were raised to keep quiet about them. It will feel edgy to lean towards opening up, and it will feel uncomfortable to trust that it’s okay to do this. You’ll catch yourself sharing masks repeatedly. And that’s okay. It’s a growth process. It takes time to peel the onion of silence, to find the true voice within, and to overcome expressive scarcity.

Share Button

Health24.com | Malaria still kills 1 100 a day. It can’t afford to lose resources to coronavirus

Today, another 1 100 people will die from malaria. The number will be repeated tomorrow, and the day after.

As a public health researcher, I embrace the idea that all lives have equal value. That our goal is much more to delay death than to stop death, as the latter is inevitable. Therefore as we mark this year’s World Malaria Day, we must emphasise the need for stronger health systems and sustained investments to tackle malaria more aggressively.

This message needs to be conveyed even more urgently than usual amid the coronavirus pandemic. Given the situation in Europe, China and the US, it is clear that Covid-19 significantly disrupts health systems and economic growth. There is genuine fear that if it continues spreading in Africa, the impact may be worse given the continent’s weaker health systems. One of the greatest concerns is the likely shift of attention and resources from control programmes of other infections, such as malaria.

Since 2000, Africa has benefited from some of the greatest efforts against malaria. This included a global coalition that has delivered more than 2 billion insecticide-treated nets to countries where malaria is endemic.

Given the extensive health gains, experts increasingly embraced the idea that malaria eradication, though ambitious, is both a feasible and a necessary goal. This remains the aim.

Recently, a strategic advisory panel set up by the World Health Organisation (WHO) five years ago released a report of a three-year study on benefits, future scenarios and feasibility of malaria elimination. Among its key recommendations is improved access to high-quality people-centred health services, adequate financing and resourcing for malaria programmes as well as stronger engagement with communities.

Unfortunately, in the context of Covid-19, many of these recommendations will be unattainable in the short and medium term. Resources will be shifted to tackle the pandemic and community engagement initiatives will be reduced to a bare minimum to achieve social distancing. Moreover, access to health facilities may be reduced for people with other common diseases such as malaria.

This will mean there will be many more deaths from malaria and other diseases.

This has happened before. Evidence from Africa’s fight against Ebola suggests that during outbreaks, many more people are indirectly killed by other diseases such as malaria, HIV and tuberculosis than by the outbreak itself.

African health authorities must therefore earnestly guard against such outcomes, and create a more rational response.

Protecting gains made against malaria

The past 20 years have seen major scientific developments. These have led to malaria deaths being cut from over 1 million to 405 000 a year.

This has been due in part to advances in treatments. Artemisinin-based treatments have replaced previous mono-therapies such as chloroquine. The new drugs have remained effective across Africa, which has largely been unaffected by treatment failures such as those observed in south-east Asia. About 4 million doses of child formulations of these treatments have been delivered, saving another 850 000 lives.

There have also been advances in prevention measures. For example, to mitigate the threat of insecticide resistance in malaria mosquitoes, scientists from private and public institutions have created new types of insecticidal bed nets and new chemical formulations for spraying houses. And countries such as Tanzania are using innovative distribution approaches involving schools so that they can maintain high coverage and access to essential malaria commodities.

But African countries don’t have resilient communities and strong health systems. This means that these past gains need to be protected vigorously.

Not all fevers are Covid-19

Initial symptoms of malaria – such as a high fever – may be similar to those of influenza and other viral infections such as Covid-19.

This underscores the need for malaria programme managers, community leaders and health workers in affected communities to continue to emphasise prompt diagnosis, effective treatment and improved prevention. But health workers and communities should not be put at any risk. Therefore essential information should be provided about both malaria and Covid-19.

In addition, special efforts will need to be made to avert indirect deaths. For example during the Ebola outbreak, a mass drug rollout was put in place in Sierra Leone to prevent malaria deaths.

Similarly, countries will require innovative approaches to ensure continued distribution of insecticide treated nets. The WHO has already sent an advisory to malaria-endemic countries on how to tailor their control efforts during the Covid-19 pandemic. Without this, Africa will bear the combined consequences of both diseases.

Since zero malaria starts with each one of us, we must keep up the malaria fight through this cloud of Covid-19.The Conversation

Fredros Okumu, Director of Science, Ifakara Health Institute

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Image credit: iStock

Share Button

Health24.com | Coronavirus morning update: Revised national budget, SA cases surge past 4 000, and Trump under fire

WHAT’S HAPPENING IN SA

Cases update: 

The latest number of confirmed cases is 4 220.

According to the latest update, 79 deaths have been recorded in the country.

So far, 152 390 tests have been conducted, with more than 8 800 new tests conducted.

READ MORE |All the confirmed cases of coronavirus in SA

Latest news:

Minister of Finance Tito Mboweni said on Friday that he would table a revised budget to Parliament which would accommodate government’s R800 billion response to the Covid-19 coronavirus pandemic.

“I will be shortly tabling a revised budget bill before Parliament to deal with all of these measures,” Mboweni said at a press briefing. He did not specify a date. 

Earlier in the week, President Cyril Ramaphosa announced the R500 billion coronavirus relief package, which included stimulus funds, allocations for salary cover and tax incentives for businesses affected by Covid-19 and the lockdown.

Mboweni said the relief package, combined with monetary policy measures from the South African Reserve Bank such as the 200 basis point cut in interest rates in less than a month, could unlock as much as R800 billion into the economy.

Without detailing the strategy in depth, Mboweni said the national budget that he tabled in February would undergo budget reallocation and reprioritisation to ensure that funds are redirected from non-essential state functions to the government’s interventions to the coronavirus.

READ MORE | Mboweni to table adjusted budget outlining coronavirus relief package

President Cyril Ramaphosa has heaped praise on Gauteng for its state-of-readiness in the midst of the increasing number of Covid-19 cases in the country.

Ramaphosa joined Premier David Makhura and Health MEC Bandile Masuku for a tour of three of the province’s facilities on Friday, which included a field hospital set up at the Nasrec expo centre, a food bank and Charlotte Maxeke Hospital.

He praised the provincial government and healthcare workers leading its response to the deadly pandemic, saying they have shown great dedication, commitment and sacrifice.

“The question of financial resources becomes easy when a province demonstrates innovation and is being far-sighted, [showing] foresight and in many ways really working hard to make sure it safeguards the life as well as the health of the people of this province.”

He said the hospital, which currently has 19 intensive care units, would be ramped up by 100.

“That is phenomenal, and in many ways this hospital, through the Covid crisis, [is] being transformed to be ready for NHI [National Health Insurance], and we are putting the building blocks in place,” he added, referring to the country’s vision of universal health care.

READ MORE | Covid-19 crisis is helping SA hospitals get ready for NHI – Ramaphosa

More than 220 000 South African workers may be due a total not far from R1 billion, the Unemployment Insurance Fund (UIF) said on Friday – but it doesn’t have the necessary information to send them their cash.

The UIF has been rapidly paying out Covid-19 benefits under the Temporary Employer / Employee Relief Scheme (TERS), but not everything has been going smoothly.

Those employees, 220 768 of them to be precise, were either not found in the UIF system or their employers did not provide enough information for their payments to be processed, the UIF said.

On average, if eligible, each would receive around R4 200.

Employers have been sent notifications in cases where details were lacking, the UIF said.

READ MORE | More than 220 000 South Africans may be missing out on nearly R1 billion in cash, the UIF says

President Cyril Ramaphosa says he has called on the Auditor-General to put in place systems that will prevent the potential looting of billions committed to the fight against the coronavirus outbreak.

He made the comments to journalists on Friday, days after announcing a R500 billion Covid-19 relief fund, of which R20 billion will be given to municipalities.

“I do not want to hear of a commission request after this. I do not want to hear of a Covid commission, therefore we want to take proactive steps,” said Ramaphosa.

The president spent most of Friday touring some of Gauteng’s facilities, which have been prepared in response to the deadly global outbreak.

READ MORE | Ramaphosa vows Covid-19 budget will not fall prey to looting

WHAT’S HAPPENING IN THE REST OF THE WORLD 

Cases update:

For the latest global data, follow this interactive map from Johns Hopkins University & Medicine.

Late on Friday night, positive cases worldwide were close to 2.8 million, while deaths were close to 196 000.

The United States has the most cases in the world – almost 890 000, as well as the most deaths – nearly 51 000.

READ MORE | All the confirmed cases worldwide

Latest news:

Experts on Friday dismissed as reckless and irresponsible US President Donald Trump’s suggestion of injecting disinfectant to treat patients with Covid-19, the disease caused by the novel coronavirus.

“Is there a way we can do something like that, by injection inside [the body]?” Trump asked at his daily briefing on Thursday, having said that disinfectant knocks out the virus “in a minute”.

“Because, you see, it gets in the lungs and it does a tremendous number on the lungs,” Trump continued, apparently referring to disinfectant. “So it would be interesting to check that out.”

In interviews and on social networks, doctors and others dismissed Trump’s idea out-of-hand.

“This notion of injecting or ingesting any type of cleansing product into the body is irresponsible, and it’s dangerous,” Vin Gupta, pulmonologist and global health expert told NBC News.

“It’s a common method that people utilise when they want to kill themselves.”

“We have already seen people mistakenly poisoning themselves by taking chloroquine when their hopes were raised by unscientific comments,” noted Parastou Donyai, director of pharmacy practice and the University of Reading, referring to a malaria drug Trump has promoted as a treatment for Covid-19.

READ MORE | ‘Irresponsible, dangerous’ – experts trash Trump idea of injecting disinfectant to treat coronavirus

The US death toll from the coronavirus pandemic surpassed 50 000 on Friday, according to a running tally by Johns Hopkins University.

According to the tracker, 50 031 people have now died in the United States from Covid-19 since the start of the global health crisis, with more than 870 000 confirmed cases.

The United States is the hardest hit of any country in the world as the coronavirus pandemic unfolds. In the 24 hours to 00:30 GMT Friday, 3 176 people died of Covid-19, according to Johns Hopkins – one of the deadliest days recorded anywhere since the start of the pandemic.

Despite the alarming figures, several US states such as Georgia and Texas were preparing to reopen some businesses as they started lifting lockdown measures.

READ MORE | US records one of the deadliest days yet as coronavirus toll exceeds 50 000 – Johns Hopkins

LATEST RESEARCH

While most of us are doing the best we can to stay as far away from the new coronavirus as possible, some people are willing to be infected intentionally.

As scientists are racing towards the development of a vaccine against the new coronavirus, a grassroots effort has attracted nearly more than 2 300 volunteers – should they be needed for such a trial.

This controversial approach is also known as a human-challenge trial.

The programme is called 1 Day Sooner and not affiliated with any groups or companies currently developing and funding coronavirus vaccines.

READ MORE | People are volunteering to be infected with the coronavirus, in a controversial vaccine approach

While most people are anxious about the coronavirus, people with underlying conditions such as diabetes may be especially so.

Earlier, more extensive research from China published in JAMA showed a 2% fatality rate among Covid-19 patients. But this rate jumped to about 10% for those who also had cardiovascular disease and to about 7% among those with diabetes. A report from Italy found among 481 patients who died of the virus, about one-third had diabetes.

That represents a risk of death five times higher than would be expected based on diabetes’ overall prevalence in Italy, said Dr Robert Eckel, an endocrinologist at the University of Colorado School of Medicine.

While there’s much to learn about Covid-19, its course in people with diabetes appears to loosely parallel that of influenza. Outcomes are less stable, ventilators are more commonly needed, and severe complications are more likely in people with diabetes who get the flu, said Eckel, current president of medicine and science at the American Diabetes Association.

The reasons are complicated. In people with type 2 diabetes, insulin resistance gives rise to chronic, low-grade inflammation, leaving the immune system dulled by this ongoing state of alert. New infections are like “crying wolf” – the immune system does not rally quickly and adequately, therefore allowing the virus to gain and maintain a foothold.

READ MORE | Understanding the risky combination of diabetes and the coronavirus

HEALTH TIPS (as recommended by the NICD and WHO)

• Maintain physical distancing – stay at least one metre away from somebody who is coughing or sneezing

• Practise frequent hand-washing, especially after direct contact with ill people or their environment

• Avoid touching your eyes, nose and mouth, as your hands touch many surfaces and could potentially transfer the virus

• Practise respiratory hygiene – cover your mouth with your bent elbow or tissue when you cough or sneeze. Remember to dispose the tissue immediately after use.

READ MORE: Coronavirus 101 

Image credit: Getty Images

Share Button

Health24.com | Woman’s breast implant probably saved her from bullet

In a remarkable case study, a woman from Ontario, Canada, had a narrow escape after being hit by a bullet in a shooting incident.

This medical case study was first published on 15 April 2020. Breast augmentation with silicone implants remains one of the most performed operations by plastic surgeons, and in this case the silicone implant was probably responsible for deflecting the bullet’s trajectory.

The woman was walking down the street when she suddenly felt heat and pain in her left breast and saw blood when she looked down. The firearm was never recovered, and the shooter remains unknown.

She was transferred to a trauma unit, where she remained in a stable condition with only one wound where the bullet entered her body. During the examination, the medical team observed a hard, bullet-like mass on the right side of her chest. X-rays confirmed that the bullet was still lodged in her body.

Implant saved her life

The bullet entered her chest on the left side and was deflected through the right thoracic wall, where it became lodged.

The woman suffered slight damage to lung tissue and a fractured rib.

The team removed the damaged implants and then the bullet. As the left implant lay over the heart and intrathoracic cavity, it is likely that it saved the women’s life, according to the case study. The X-rays and clinical examination prove that if it weren’t for the implant, the bullet might have struck her heart.

“Based on trajectory of bullet entry clinically and evaluation radiologically, the only source of bullet deflection of the bullet is the left breast implant,” the authors stated in the report.

“This trajectory change could only have been due to the bullet hitting the implant in our patient’s case, as the bullet did not hit bone on the left side (as evidenced by lack of left-sided fracture and a bullet that retained enough energy to cause right-sided fractures).”

Image credit:

Share Button

Coronavirus: Plea for public to get medical care when they need it

People needing help should not be put off by the coronavirus pandemic, say health professionals.

Share Button